Wyntra is a pharmaceutical company commercializing complex and differentiated prescription medicines
Our core markets are the United States of America and the United Kingdom
The leadership team have deep sector in-market and international experience across specialty and generic pharmaceuticals
Novel products and solutions,
new ways of working
For our patients, employees, stakeholders and our world
Open, honest, respectful
in everything we do
Partners who use renewable energy sources
Digital supply chain control tower
Community and charity partners
Hybrid working practices
Mental health support
The Leadership Team’s international experience spans a wide range of specialty and generics organisations
Chief Executive Officer
As Chief Executive Officer, Terry Coughlin oversees the entire Wyntra business with a special focus on US commercialization.
A seasoned life sciences leader with over 30 years in global pharmaceuticals and young start-up organisations, Terry has significant experience of corporate transformation and growth, and a deep knowledge of the finished dosage and active ingredient markets in both the US and India.
Terry served as CEO at Strides Pharma USA and Glenmark, and as COO at Endo International, in addition to previous roles at Dr Reddy’s and Wyckoff Chemical. His management experience spans sales, marketing, manufacturing and operations in multiple locations across the US and India.
Terry holds a BS degree in chemistry from Central Michigan University.
Chief Commercial Officer
As Chief Commercial Officer, Rahul Garella manages the global commercial function at Wyntra.
With over 27 years of international experience in specialty and generic pharmaceuticals, Rahul has a deep understanding of the drivers of commercial and operational growth and profitability.
Rahul was the CCO for international markets at Strides Pharma, and EVP for international markets at Endo Pharmaceuticals. Previously Rahul held senior positions at PAR Pharmaceutical and Glenmark.
Rahul holds a BEng degree in engineering from the JMI University of New Delhi and an MBA from IMT Ghaziabad.
Chief Operations Officer
As Chief Operations Officer, Rahul Dhorajiwala is in charge of global operations at Wyntra.
Rahul is a pharmaceutical scientist with more than 25 years' experience in drug development and launch.
Rahul was director of global Launches at Advanz, delivering more than 100 licensing and development projects. Previously, Rahul held management roles at Glenmark, IVAX and GSK. His primary expertise lies in project management and business development, with deep experience also in formulation, quality, supply chain, and regulatory affairs.
Rahul holds a BSc degree in Pharmaceutical Science from De Montfort University and an MSc in Pharmaceutical Technology from King’s College, London.
Retail and Hospital
+Device (PFS, Bags)
PoM to P/Rx to OTC